Giant solitary fibrous tumor of the pelvis successfully treated with preoperative embolization and surgical resection: a case report by unknown
WORLD JOURNAL OF 
SURGICAL ONCOLOGY
Yokoyama et al. World Journal of Surgical Oncology  (2015) 13:164 
DOI 10.1186/s12957-015-0578-6CASE REPORT Open AccessGiant solitary fibrous tumor of the pelvis
successfully treated with preoperative
embolization and surgical resection: a case report
Yuichiro Yokoyama*, Keisuke Hata, Takamitsu Kanazawa, Hironori Yamaguchi, Soichiro Ishihara, Eiji Sunami,
Joji Kitayama and Toshiaki WatanabeAbstract
Solitary fibrous tumors (SFTs) rarely develop in the pelvis. When they do arise, they are usually treated using
surgery, although SFTs are often very large by the time of diagnosis, which makes surgical excision difficult. We
report a case of a 63-year-old man who was referred to our hospital for the treatment of a giant tumor of the pelvis.
Computed tomography (CT) revealed a 30 × 25 × 19 cm sized hypervascular tumor that almost completely filled the
pelvic cavity. The diagnosis of SFT was made by CT-assisted needle biopsy. The feeding arteries of the tumor were
embolized twice. The first embolization aimed to reduce the tumor volume, while the second one was planned a
day prior to the surgery to obtain hematostasis during the operation. Tumor resection was then performed. The
blood loss during the operation was 440 ml, and there was no uncontrollable bleeding. The postoperative course
was uneventful. No recurrence of SFT was observed during a 2-year follow-up.
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Solitary fibrous tumor (SFT) is a rare mesenchymal
tumor that was first documented by Klemperer and
Rabin [1]. Although SFTs mainly develop in the pleura,
they have also been found in various extra-thoracic sites,
such as the peritoneum, liver, thymus, thyroid, intrapul-
monary parenchyma, and nasal cavity [2]. Thirty percent
of SFTs occur in the abdominopelvic region, making it
one of the major primary sites for this tumor [3]. Surgi-
cal resection is the treatment of choice for SFTs. How-
ever, abdominopelvic SFTs are often very large by the
time of diagnosis, which makes surgical resection diffi-
cult. Because of their rarity, the preoperative manage-
ment for the safe resection of abdominopelvic SFTs has
not been fully defined. Here, we report a case of a giant
pelvic SFT that was successfully resected following pre-
operative embolization of the feeding arteries.* Correspondence: yyokoyama1549@gmail.com
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A 63-year-old man presented to another hospital with fre-
quent urination was diagnosed as having a very large pel-
vic tumor. He was referred to our hospital for further
treatment. He had a history of medical treatment for dia-
betes from the age of 53. Physical examination showed a
large painless mass in the lower abdomen. Laboratory
examination, including tumor markers, revealed no abnor-
malities except for a positive treadmill exercise test. Com-
puted tomography (CT) and magnetic resonance imaging
(MRI) revealed a huge mass, measuring 30 × 25 × 19 cm,
which occupied the pelvic cavity and was suggestive of a
malignant mesenchymal tumor (Figure 1A,B). The size of
the tumor had increased by 20% in 2 months since he was
first diagnosed at the other hospital. Angiography revealed
a hypervascular tumor fed mainly by the left obturator ar-
tery, left internal pudendal artery, and left superior vesical
artery (Figure 1C). CT-assisted needle biopsy was con-
ducted to enable a pathological diagnosis. Histopatho-
logical examination revealed CD34-positive proliferating
spindle cells in a collagenous matrix, suggestive of SFT.
Coronary angiography showed total occlusion of the left
anterior descending coronary artery, hypoplasia of the lefttral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Preoperative computed tomography (CT), angiography before embolization, and plain CT after embolization with lipiodol and
N-butyl-2-cyanoacrylate. (A), (B) Preoperative CT showed a giant pelvic mass lesion, measuring 30 × 25 × 19 cm. (C) Angiography of the left
iliac artery revealed that the mass was mainly supplied by the left obturator artery (black arrow), left internal pudendal artery (white arrow), and
left superior vesical artery (red arrow). (D), (E), (F) CT after embolization showed that lipiodol and N-butyl-2-cyanoacrylate were well distributed
to the left obturator artery (black arrow), left internal pudendal artery (white arrow), and left superior vesical artery (red arrow), demonstrating
successful embolization of the target vessels.
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coronary artery. Percutaneous coronary intervention was
therefore scheduled postoperatively. In order to reduce
the tumor volume, the feeding arteries of the tumor were
embolized. However, 1 month after the first embolization,
CT revealed that the tumor had not reduced in size. Elect-
ive surgery was planned, and the second embolization of
feeding arteries with lipiodol and N-butyl-2-cyanoacrylate
was conducted a day prior to the operation to prevent un-
controllable bleeding (Figure 1D,E,F). Laparotomy was
then performed through a midline incision. The tumor to-
tally occupied the pelvic cavity. It seemed to have grown
expansively and was grossly well circumscribed, but it had
also partly adhered to the left pelvic wall. Its surface was
covered by a plexiform meshwork of large dilated vessels
that were susceptible to hemorrhage. Vessels entering the
tumor were carefully ligated. The tumor did not invade
the rectum or bladder and could be safely resected with-
out massive bleeding. The needle biopsy tract was not
resected. The total blood loss was 440 ml and no blood
transfusion was needed. The resected tumor measured
30 × 25 × 15 cm. Macroscopically, the resected specimen
was an encapsulated mass with focal hemorrhages andnecrosis. The cut surface was solid and grayish-white
(Figure 2A). Microscopic findings were of proliferating
round and spindle cells, which exhibited a disordered
arrangement in a collagenous matrix without significant
cytological atypia (Figure 2B). The mitosis rate was low
(<1/10 high-power fields), and only 1% of tumor cells
were MIB-1 positive. Immunohistochemical staining
demonstrated that the tumor cells were positive for
CD34, vimentin, and Bcl-2, and negative for Desmin, S-
100, and c-kit (Figure 2C), which was diagnostic for
SFT. The postoperative course was uneventful, and no
recurrence was apparent two years after surgery.
Discussion
SFT was first described by Klemperer and Rabin in 1931
as a localized fibrous mesothelioma, but it is now recog-
nized that SFTs can originate in various extra-thoracic
sites. The age of onset of SFTs is around 50 to 60 years,
and the male-to-female ratio appears to be almost equal
[4]. Surgical resection is the treatment of choice for both
abdominopelvic SFTs and those that arise in other or-
gans. No standard therapy has been established for inop-
erable SFTs, and their surgical resectability is the most
Figure 2 Macroscopic, microscopic, and immunohistological tumor findings. (A) Gross appearance of the resected tumor. (B) Microscopic
findings were of a disordered arrangement of spindle cells (×100, original magnification). (C) Immunohistochemical staining revealed that tumor
cells were positive for CD34 (×200, original magnification).
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the tumor is curative in more than 90% of cases. How-
ever, abdominopelvic SFTs often remain asymptomatic
and undiagnosed until they are very large. Indeed, Wang
et al. reported that the diameters of abdominopelvic
SFTs ranged between 2.5 and 28 cm (mean, 12.7 cm),
which sometimes makes surgical resection difficult. In
our case, the maximum diameter of the tumor was lar-
ger than in previous reports [2-4]. In general, neoadju-
vant therapies were applied for unresectable gigantic
tumors after a preoperative diagnosis was made. How-
ever, because of their rarity, the preoperative manage-
ment of abdominopelvic SFTs has not been defined.
In the present case, CT revealed a giant mass that
filled the pelvic cavity. The preoperative assessment re-
vealed the patient had ischemic heart disease. To resect
this tumor safely, the preoperative diagnosis was vital in
order to determine the appropriate neoadjuvant therapy.
On CT and MRI scans, SFTs are usually heterogeneous,
with hypervascular areas showing intense enhancement,
hypercellular areas showing moderate enhancement, and
areas of cystic, myxoid degeneration, or necrosis showing
no enhancement. However, these imaging characteristics
are also observed in other hypervascular tumors with fi-
brous content, including most sarcomas, gastrointestinal
stroma tumors, and malignant peripheral nerve sheath tu-
mors, and hence, it is difficult to differentiate these tumors
by CT and MRI findings alone [4]. Fluorodeoxyglucose
positron-emission tomography shows heterogeneous ac-
cumulation of fluorodeoxyglucose, and ultrasonography
reveals a heterogeneous echotexture tumor; however,
these are not specific features for SFTs [6]. Indeed, in our
case, enhancing CT could only indicate that this tumor
was possibly a malignant mesenchymal tumor, and it did
not allow a definitive diagnosis. These indistinct imaging
findings explain why abdominopelvic SFTs are diagnosed
postoperatively in most cases [3]. As we were not able to
make a diagnosis based on CT findings, we performed aneedle biopsy. The risk associated with a percutaneous
core biopsy seemed to be minimal, and only a few cases of
tumor seeding of sarcomas after this procedure have been
reported [7-9]. Therefore, a needle biopsy was taken in
order to obtain a preoperative diagnosis, which allowed a
definitive diagnosis of SFT to be made.
The reported success of neoadjuvant therapy for SFTs
has varied. Combs et al. reported that radiotherapy was ef-
fective in controlling SFTs of the central nervous system
and spine, and some good results with radiotherapy have
also been reported for abdominopelvic SFTs [10-13]. On
this basis, irradiation is a candidate neoadjuvant therapy,
although other studies have given disappointing results,
and the efficacy of radiotherapy for SFTs continues to be
debated [3]. Adriamycin or a combination of cyclophos-
phamide, vincristine, doxorubicin, and dacarbazine have
been considered to be the most effective chemotherapeu-
tic treatments for SFTs, but they have not been shown to
prolong overall survival [12,13].
Unlike the approached described above, preoperative
percutaneous embolization of feeding arteries has been
shown to allow a safe, complete resection to be performed,
especially in cases of thoracic, cervical, and spinal SFTs
[14-16]. In the case of abdominopelvic SFTs, a few reports
have described but not emphasized the use of preoperative
embolization, and most other reports have not discussed its
importance [6,17]. The resection of giant pelvic tumors,
even if they are benign, is usually complicated by difficulties
in visualizing the operative field, and the resection of giant
pelvic hypervascular tumors such as SFTs is sometimes
very dangerous. Indeed, a massive transfusion was needed
in several cases of abdominopelvic SFT resection, and in
two cases, patients died postoperatively of hemorrhagic
shock [18,19]. In our case, angiography revealed a hyper-
vascular tumor that was fed by branches of the left internal
iliac artery. Hence, embolization of the feeding arteries was
performed to shrink the tumor and to prevent bleeding
during the operation. Potential severe complications of
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These complications have been reported in the stomach,
spleen, and kidney, but they rarely occur in the pelvis [20].
Unfortunately, the first embolization failed to reduce the
tumor volume, although it prevented further tumor growth.
The second embolization was successfully performed, lead-
ing to a safe resection without blood transfusion. In our
case, the size of tumor was larger than that of previous re-
ports, nevertheless the postoperative course was uneventful,
and no recurrence was observed 2 years after surgery.
Conclusion
Preoperative diagnosis and the embolization of feeding
arteries are essential for the successful complete surgical
resection of giant abdominopelvic SFTs.
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